Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

Come May 22, compounding pharmacies must stop making semaglutide injections, which serve as a more affordable generic ...

Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...